U.S. Markets open in 2 hrs 10 mins
  • S&P Futures

    3,910.50
    -12.00 (-0.31%)
     
  • Dow Futures

    31,919.00
    +3.00 (+0.01%)
     
  • Nasdaq Futures

    13,176.50
    -125.50 (-0.94%)
     
  • Russell 2000 Futures

    2,289.00
    +3.90 (+0.17%)
     
  • Crude Oil

    63.38
    +0.16 (+0.25%)
     
  • Gold

    1,784.40
    -13.50 (-0.75%)
     
  • Silver

    28.02
    +0.10 (+0.35%)
     
  • EUR/USD

    1.2241
    +0.0073 (+0.5998%)
     
  • 10-Yr Bond

    1.3890
    0.0000 (0.00%)
     
  • Vix

    22.57
    -0.54 (-2.34%)
     
  • GBP/USD

    1.4143
    +0.0002 (+0.0113%)
     
  • USD/JPY

    106.1360
    +0.2540 (+0.2399%)
     
  • BTC-USD

    50,334.14
    -97.13 (-0.19%)
     
  • CMC Crypto 200

    1,006.34
    +11.68 (+1.17%)
     
  • FTSE 100

    6,686.14
    +27.17 (+0.41%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

A Look At Benzinga Pro's Most-Searched Tickers For September 30, 2019

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Hal Lindon
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

  1. Dova Pharmaceuticals (NASDAQ: DOVA) shares were up 38.5% to $27.99 after the company announced it would be acquired by Orphan Biovitrum for $29 per share, of which $27.50 is to be paid upfront in cash.

  2. Bed Bath & Beyond (NASDAQ: BBBY) shares were up 7% to $10.58. Wedbush upgraded the stock from Neutral to Outperform and raised the price target from $14 to $16.

  3. TrovaGene (NASDAQ: TROV) shares were up 14.5% to $1.68 after the company reported positive data from its phase 1b/2 study of onvansertib in patients with relapsed/refractory acute myeloid leukmia.

  4. Mallinckroft (NYSE: MNK) shares were up 1.8% to $2.29 after the company reported it settled opiod cases in Cuyahoga and Summit counties in Ohio.

  5. Sienna Biopharmaceuticals (NASDAQ: SNNA) shares were up 57% to $0.18 on higher the average volume at 25 million shares traded for the session.

  6. Seattle Genetics(NASDAQ: SGEN) shares were up 11.4% to $84.70 after after Piper Jaffray maintained an Overweight rating on the stock and raised the price target from $75 to $95. The company presented compelling initial data from the EV-103 study, which compared favorably to the current standard of care.

  7. Micron Technology (NASDAQ: MU) shares were down 0.9% to $42.84.

  8. Newell Brands (NASDAQ: NWL) shares were up 6.7% to $19.42. SunTrust Robinson Humphrey upgraded the stock from Hold to Buy and raised the price target from $15 to $25 per share.

  9. Immunomedics (NASDAQ: IMMU) shares were down 13.7% to $12.37 after the interim data from its phase 2 study of sacituzumab govitecan showed a 29% response rate.

  10. Alibaba Group Holding (NYSE: BABA) shares were up 1.6% to $168.76.

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.